@EMManchester @yvette_ruddock @dralangrayson @drgarethroberts @mmbangor @DLGDen Severe asthma - almost an "evidence-free" zone... Cochrane reviews suggest: (1) Addition of IV beta-agonists... "three trials involving 104 people (75 children and 29 adults)
Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. - PubMed - NCBI فنتولين وريد https://t.co/5QbKZ9oaHx
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Review. http://t.co/gaxyawzc
There is very limited evidence from one study (Browne 1997) to support the use of IV beta2-agonists in children... http://t.co/y2yVnt1A
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Review. http://t.co/TMLCwBkw
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Review. http://t.co/xrSQ5pE0
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Review. http://t.co/gaxyawzc
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Review. http://t.co/TMLCwBkw
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Review. http://t.co/WJBq2Olo
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma http://t.co/iYkQ886J
Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. http://t.co/cdWKQV7d